+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Canine Arthritis Market by Treatment Type, Drug Class, Route Of Administration, Distribution Channel, End User, Company - Global Forecast to 2030- Product Image
Canine Arthritis Market by Treatment Type, Drug Class, Route Of Administration, Distribution Channel, End User, Company - Global Forecast to 2030- Product Image
Sale

Canine Arthritis Market by Treatment Type, Drug Class, Route Of Administration, Distribution Channel, End User, Company - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010632
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The canine arthritis market is undergoing a transformation, driven by demographic shifts among companion animals, increased focus on animal well-being, and dynamic advancements in therapeutic solutions. Senior leaders in veterinary healthcare, animal health pharma, and distribution will find direct, actionable insights into changing care pathways, regulatory environments, and emerging collaborations across the global value chain in this market research report.

Market Snapshot: Canine Arthritis Market Growth and Trajectory

The canine arthritis market grew from USD 1.92 billion in 2024 to USD 2.08 billion in 2025. It is expected to continue growing at a CAGR of 8.21%, reaching USD 3.09 billion by 2030. This expansion reflects rising pet longevity, increased owner awareness, and mounting investment in both innovative and integrated arthritis therapies for dogs. Veterinary clinics, pharmaceutical companies, and digital health providers are positioned at the intersection of technological innovation and daily clinical challenges, shaping the market’s rapid evolution.

Scope & Segmentation

This report provides a detailed breakdown of the canine arthritis market, structured to support strategic planning for business expansion, portfolio management, and channel selection. The comprehensive analysis encompasses:

  • Treatment Types: Complementary therapies, including nutraceuticals and supplements such as chondroitin, glucosamine, and omega fatty acids; non-pharmacological treatments like acupuncture, laser therapy, hydrotherapy, and physiotherapy; and pharmacological modalities, covering disease-modifying agents, monoclonal antibodies like bedinvetmab, and established NSAIDs such as carprofen, deracoxib, and meloxicam.
  • Drug Classes: Disease modifying osteoarthritic agents, monoclonal antibodies, and non-steroidal anti-inflammatory drugs.
  • Routes of Administration: Subcutaneous injectables, oral tablets or capsules, and topical gels.
  • Distribution Channels: Online pharmacies (both general e-commerce and vet-specific), retail pharmacies, pet specialty stores, and veterinary hospital pharmacies.
  • End Users: Specialty pet clinics, rehabilitation centers, veterinary clinics (general and orthopedic), and multispecialty or small animal hospitals.
  • Company Coverage: Profiles and competitive positioning for Dechra, Elanco, Zoetis, Merck & Co., Vetoquinol, Virbac, Boehringer Ingelheim, Nutramax Laboratories, Colgate-Palmolive, and Nestlé, among others.
  • Regions Profiled: Americas (with details for the U.S. and major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including leading European countries and select regions in the Middle East and Africa), and Asia-Pacific (featuring China, Japan, Australia, India, South Korea, and Southeast Asia).

Key Takeaways for Strategic Leaders

  • Biologics and monoclonal antibody innovations are shaping new precision therapies in canine arthritis, establishing distinct treatment pathways beyond traditional NSAIDs.
  • The integration of multimodal care—combining pharmacological, non-pharmacological, and complementary options—is influencing clinical standards and spurring collaboration across pharmaceutical developers, clinics, and digital solution providers.
  • Digital engagement, including telemedicine and e-commerce, is transforming pet owner education, product access, and end-to-end visibility of outcomes, supporting efficient care delivery and expanding distribution reach.
  • Regional dynamics demand tailored go-to-market approaches, with North America leading in rapid product adoption, Western Europe advancing biologics and diagnostics, and Asia-Pacific displaying high growth through localized manufacturing and premium veterinary services.
  • Ongoing partnerships among veterinary hospitals, academic institutes, and industry leaders are fostering evidence generation for newer therapies and driving the adoption of digital monitoring tools.

Tariff Impact: Market Realignment and Strategic Response

The introduction of 2025 U.S. tariffs has influenced the supply chain for canine arthritis therapies. Increased costs for raw materials like hyaluronic acid and key excipients have prompted manufacturers to reassess sourcing strategies and partner more closely with regional suppliers. Compliance requirements and clearance delays have led distributors and veterinary hospitals to adjust their inventories and logistics. As import duties impact adjunctive therapies, demand has shifted toward domestically produced products, accelerating moves toward localized production and new joint ventures.

Methodology & Data Sources

This report applies a multi-sourced research approach that links in-depth interviews with industry leaders, veterinary professionals, and pet rehabilitation experts with survey data from pet owners. Peer-reviewed clinical studies, regulatory documentation, trade statistics, and public company filings supplement primary research. Data triangulation ensures that all insights reflect real-world market dynamics, validated through clinic-level performance metrics and patent analysis.

Why This Report Matters

  • Informs portfolio and channel strategy by mapping evolving treatment preferences, digital engagement trends, and regional differences in market maturity.
  • Enables timely response to supply chain shifts and policy changes, equipping leadership to maintain market access and business continuity.
  • Supports evidence-based investment in innovation, digital health solutions, and cross-sector partnerships for sustained growth and patient benefit.

Conclusion

Leadership teams equipped with these insights can define precise strategies addressing both immediate market shifts and long-term opportunities in canine arthritis care. Proactive collaboration and innovation will be critical to achieving growth and improved patient outcomes across the canine health sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Canine Arthritis Market, by Treatment Type
8.1. Introduction
8.2. Complementary Therapies
8.2.1. Nutraceuticals
8.2.2. Supplements
8.2.2.1. Chondroitin
8.2.2.2. Glucosamine
8.2.2.3. Omega Fatty Acids
8.3. Non Pharmacological Therapies
8.3.1. Acupuncture
8.3.2. Laser Therapy
8.3.3. Physical Therapy
8.3.3.1. Hydrotherapy
8.3.3.2. Physiotherapy
8.4. Pharmacological Therapies
8.4.1. Disease Modifying Agents
8.4.1.1. Hyaluronic Acid
8.4.1.2. Polysulfated Glycosaminoglycan
8.4.2. Monoclonal Antibodies
8.4.2.1. Bedinvetmab
8.4.3. Non Steroidal Anti Inflammatory Drugs
8.4.3.1. Carprofen
8.4.3.2. Deracoxib
8.4.3.3. Meloxicam
9. Canine Arthritis Market, by Drug Class
9.1. Introduction
9.2. Disease Modifying Osteoarthritic Agents
9.2.1. Hyaluronic Acid
9.2.2. Polysulfated Glycosaminoglycan
9.3. Monoclonal Antibodies
9.3.1. Bedinvetmab
9.4. Non Steroidal Anti Inflammatory Drugs
9.4.1. Carprofen
9.4.2. Deracoxib
9.4.3. Meloxicam
10. Canine Arthritis Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Subcutaneous
10.3. Oral
10.3.1. Tablet Capsule
10.4. Topical
10.4.1. Gel
11. Canine Arthritis Market, by Distribution Channel
11.1. Introduction
11.2. Online Pharmacies
11.2.1. General E Commerce Platforms
11.2.2. Vet E Commerce Platforms
11.3. Pet Specialty Stores
11.4. Retail Pharmacies
11.5. Veterinary Hospital Pharmacies
12. Canine Arthritis Market, by End User
12.1. Introduction
12.2. Specialty Pet Clinics
12.2.1. Rehabilitation Centers
12.3. Veterinary Clinics
12.3.1. General Practice Clinics
12.3.2. Orthopedic Clinics
12.4. Veterinary Hospitals
12.4.1. Multispecialty Hospitals
12.4.2. Small Animal Hospitals
13. Canine Arthritis Market, by Company
13.1. Introduction
13.2. Dechra
13.3. Elanco
13.4. Zoetis
14. Americas Canine Arthritis Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Canine Arthritis Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Canine Arthritis Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Zoetis Inc.
17.3.2. Elanco Animal Health Incorporated
17.3.3. Merck & Co., Inc.
17.3.4. Dechra Pharmaceuticals PLC
17.3.5. Vetoquinol SA
17.3.6. Virbac SA
17.3.7. Boehringer Ingelheim International GmbH
17.3.8. Nutramax Laboratories, Inc.
17.3.9. Colgate-Palmolive Company
17.3.10. Nestlé S.A.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CANINE ARTHRITIS MARKET MULTI-CURRENCY
FIGURE 2. CANINE ARTHRITIS MARKET MULTI-LANGUAGE
FIGURE 3. CANINE ARTHRITIS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CANINE ARTHRITIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CANINE ARTHRITIS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CANINE ARTHRITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANINE ARTHRITIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CHONDROITIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GLUCOSAMINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY OMEGA FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYDROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSIOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BEDINVETMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY POLYSULFATED GLYCOSAMINOGLYCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY BEDINVETMAB, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY CARPROFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DERACOXIB, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MELOXICAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TABLET CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GENERAL E COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VET E COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY PET SPECIALTY STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY MULTISPECIALTY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY SMALL ANIMAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY DECHRA, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ELANCO, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CANINE ARTHRITIS MARKET SIZE, BY ZOETIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES CANINE ARTHRITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 134. CANADA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 135. CANADA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 136. CANADA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 137. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 138. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 139. CANADA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 140. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 141. CANADA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 142. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 143. CANADA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 145. CANADA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 146. CANADA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 147. CANADA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 148. CANADA CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 149. CANADA CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 150. CANADA CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 151. CANADA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. CANADA CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 153. CANADA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. CANADA CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 155. CANADA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 156. CANADA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. CANADA CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 158. MEXICO CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 159. MEXICO CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 161. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 162. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 163. MEXICO CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 164. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 165. MEXICO CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 166. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 167. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 168. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 169. MEXICO CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 170. MEXICO CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 171. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. MEXICO CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 173. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 174. MEXICO CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 175. MEXICO CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. MEXICO CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. MEXICO CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. MEXICO CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 187. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 188. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 189. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 190. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 191. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 192. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 193. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 194. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 195. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 197. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 198. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 199. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 201. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 203. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 204. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. BRAZIL CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 208. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 209. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 210. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 211. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 212. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 213. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 214. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 215. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 216. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 217. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 218. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 219. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 221. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 222. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 223. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 225. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 227. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. ARGENTINA CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA CANINE ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 258. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 260. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 262. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 264. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 266. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 268. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 278. UNITED KINGDOM CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 279. GERMANY CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 280. GERMANY CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 281. GERMANY CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 282. GERMANY CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 283. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 284. GERMANY CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 285. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 286. GERMANY CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 287. GERMANY CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 288. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 289. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 290. GERMANY CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 291. GERMANY CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 292. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 293. GERMANY CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 294. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 295. GERMANY CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 296. GERMANY CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. GERMANY CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 298. GERMANY CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. GERMANY CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 300. GERMANY CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 301. GERMANY CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. GERMANY CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 303. FRANCE CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 304. FRANCE CANINE ARTHRITIS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 305. FRANCE CANINE ARTHRITIS MARKET SIZE, BY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 306. FRANCE CANINE ARTHRITIS MARKET SIZE, BY NON PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 307. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 308. FRANCE CANINE ARTHRITIS MARKET SIZE, BY PHARMACOLOGICAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 309. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING AGENTS, 2018-2030 (USD MILLION)
TABLE 310. FRANCE CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 311. FRANCE CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 312. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 313. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DISEASE MODIFYING OSTEOARTHRITIC AGENTS, 2018-2030 (USD MILLION)
TABLE 314. FRANCE CANINE ARTHRITIS MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2030 (USD MILLION)
TABLE 315. FRANCE CANINE ARTHRITIS MARKET SIZE, BY NON STEROIDAL ANTI INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
TABLE 316. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. FRANCE CANINE ARTHRITIS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 318. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ORAL, 2018-2030 (USD MILLION)
TABLE 319. FRANCE CANINE ARTHRITIS MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
TABLE 320. FRANCE CANINE ARTHRITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. FRANCE CANINE ARTHRITIS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 322. FRANCE CANINE ARTHRITIS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 323. FRANCE CANINE ARTHRITIS MARKET SIZE, BY SPECIALTY PET CLINICS, 2018-2030 (USD MILLION)
TABLE 324. FRANCE CANINE ARTHRITIS MARKET SIZE, BY VETERINARY CLINICS, 2018-2030 (USD MILLION)
TABLE 325. FRANCE CANINE ARTHRITIS MARKET SIZE, BY VETERINARY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 326. FRANCE CANINE ARTHRITIS MARKET SIZE, BY COMPANY, 2018-2030 (USD MILLION)
TABLE 327. RUSSIA CANINE ARTHRITIS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 328. RUSSIA CANINE ART

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Canine Arthritis market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Virbac SA
  • Boehringer Ingelheim International GmbH
  • Nutramax Laboratories, Inc.
  • Colgate-Palmolive Company
  • Nestlé S.A.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.09 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Canine Arthritis Treatment - Global Strategic Business Report - Product Image

Canine Arthritis Treatment - Global Strategic Business Report

  • Report
  • 214 Pages
  • Global
From
Canine Arthritis Treatment Market 2025-2029 - Product Image

Canine Arthritis Treatment Market 2025-2029

  • Report
  • 215 Pages
  • Global
From
Canine Arthritis Treatment Market Report 2025 - Product Image

Canine Arthritis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1 - Product Image

Drug Therapy for Infectious Diseases of the Dog and Cat. Edition No. 1

  • Book
  • 328 Pages
Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032 - Product Image

Canine Atopic Dermatitis Market Report by Drug Class Type, Route of Administration, Distribution Channel, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From

About the Canine Arthritis Drugs Market

The Canine Arthritis Drugs market is a segment of the Animal Pharmaceuticals industry that focuses on providing medications to treat arthritis in dogs. These drugs are typically used to reduce inflammation and pain, as well as to slow the progression of the disease. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). In addition, supplements such as glucosamine and chondroitin are often used to help manage the symptoms of arthritis. The Canine Arthritis Drugs market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Zoetis, Elanco, Merck Animal Health, Bayer Animal Health, and Ceva Animal Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.